These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 12630765

  • 1. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K, Ethridge RT, Evers BM.
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [Abstract] [Full Text] [Related]

  • 2. PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells.
    Elnemr A, Ohta T, Iwata K, Ninomia I, Fushida S, Nishimura G, Kitagawa H, Kayahara M, Yamamoto M, Terada T, Miwa K.
    Int J Oncol; 2000 Dec; 17(6):1157-64. PubMed ID: 11078801
    [Abstract] [Full Text] [Related]

  • 3. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y.
    Cancer Res; 2000 Oct 01; 60(19):5558-64. PubMed ID: 11034103
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon DY, Hong JT.
    J Pharmacol Exp Ther; 2003 Nov 01; 307(2):505-17. PubMed ID: 12966153
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
    Cheng J, Nakamura H, Imanishi H, Liu W, Morisaki T, Sugiyama T, Hada T.
    Biochem Biophys Res Commun; 2004 Sep 17; 322(2):458-64. PubMed ID: 15325252
    [Abstract] [Full Text] [Related]

  • 6. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 17; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
    Shimada T, Kojima K, Yoshiura K, Hiraishi H, Terano A.
    Gut; 2002 May 17; 50(5):658-64. PubMed ID: 11950812
    [Abstract] [Full Text] [Related]

  • 8. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
    Itami A, Watanabe G, Shimada Y, Hashimoto Y, Kawamura J, Kato M, Hosotani R, Imamura M.
    Int J Cancer; 2001 Nov 01; 94(3):370-6. PubMed ID: 11745416
    [Abstract] [Full Text] [Related]

  • 9. Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2.
    Hashimoto K, Farrow BJ, Evers BM.
    Pancreas; 2004 Mar 01; 28(2):153-9. PubMed ID: 15028947
    [Abstract] [Full Text] [Related]

  • 10. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S, Simonin MA, Bianchi A, Compe E, Liagre B, Mainard D, Bécuwe P, Dauça M, Netter P, Terlain B, Bordji K.
    FEBS Lett; 2001 Jul 13; 501(1):24-30. PubMed ID: 11457450
    [Abstract] [Full Text] [Related]

  • 11. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.
    Leung WK, Bai AH, Chan VY, Yu J, Chan MW, To KF, Wu JR, Chan KK, Fu YG, Chan FK, Sung JJ.
    Gut; 2004 Mar 13; 53(3):331-8. PubMed ID: 14960510
    [Abstract] [Full Text] [Related]

  • 12. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG.
    Br J Pharmacol; 2004 Feb 13; 141(3):517-25. PubMed ID: 14718259
    [Abstract] [Full Text] [Related]

  • 13. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
    Takashima T, Fujiwara Y, Higuchi K, Arakawa T, Yano Y, Hasuma T, Otani S.
    Int J Oncol; 2001 Sep 13; 19(3):465-71. PubMed ID: 11494023
    [Abstract] [Full Text] [Related]

  • 14. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M, Nakamori S, Okami J, Hayashi N, Hiraoka N, Nagano H, Dono K, Umeshita K, Sakon M, Monden M.
    Exp Cell Res; 2003 Sep 10; 289(1):143-51. PubMed ID: 12941612
    [Abstract] [Full Text] [Related]

  • 15. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
    Ray DM, Akbiyik F, Phipps RP.
    J Immunol; 2006 Oct 15; 177(8):5068-76. PubMed ID: 17015690
    [Abstract] [Full Text] [Related]

  • 16. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
    Liu H, Zang C, Fenner MH, Possinger K, Elstner E.
    Breast Cancer Res Treat; 2003 May 15; 79(1):63-74. PubMed ID: 12779083
    [Abstract] [Full Text] [Related]

  • 17. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF, Zhang YH, Breyer RM, Davis L, Breyer MD.
    Neoplasia; 1999 Oct 15; 1(4):330-9. PubMed ID: 10935488
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E.
    Leuk Res; 2004 Apr 15; 28(4):387-97. PubMed ID: 15109539
    [Abstract] [Full Text] [Related]

  • 19. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 15; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H, Di Battista JA, Pelletier JP, Mineau F, Ranger P, Martel-Pelletier J.
    Arthritis Rheum; 2001 Mar 15; 44(3):595-607. PubMed ID: 11263774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.